참고문헌
- Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31 https://doi.org/10.1038/nm0195-27
- Folkman J, Shing Y: Angiogenesis. J BioI Chem. 1992;267:10931-10934
- Folkman J, Klangsburn M: Angiogenetic factors. Science. 1987;235:442-447 https://doi.org/10.1126/science.2432664
- Cotran RS, Kumar V, Collins T: Robbins pathologic basis of disease. 6th ed. Philadelphia: WB Saunders, 1999:301-302
- Bremer GL, Tiebosch AT, van der Putten HW, Schouten HJ, de Haan J, Arends JW: Tumor angiogenesis: an independent prognostic parameter in cervical cancer. Am J Obstet Gynecol. 1996;174:126-131 https://doi.org/10.1016/S0002-9378(96)70384-8
- Shibuya M: Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res. 1995;67:281-316 https://doi.org/10.1016/S0065-230X(08)60716-2
- Jeong SJ, Park SJ, Cha SJ, et al: VEGF expression and MVD in ductal carcinoma of breast. J Korean Cancer Assc. 1999;31:1168-1678
- Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-953
- Park CS, Chung WY, Sub JH, Kim HG: An immunohistochemical study of tumar angiogenesity and EMA reactivity in papillary thyroid carcinoma. J Korean Cancer Assoc. 1997;29:454-465
- Jeon MY,Sol MY, Park KS, Yoon HK: Microvessel density and vascular endothelial growth factor expression in invasive breast carcinomas. Korean J Pathol. 2000;34:138-144
- Cohn K, Backdahl M, Forsslund G, Auer G, Lundell G, Lowhagen T: Prognostic value of nuclear DNA content in papillary thyroid carcinoma. World J Surg. 1984;8:474-480 https://doi.org/10.1007/BF01654917
- Basolo F, Pinchera, Fugazzola L, et al: Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer. Eur J Cancer. 1994;30:171-174 https://doi.org/10.1016/0959-8049(94)90081-7
- Ryu KS, Sol MY, Yim HE, Kim MW: Correlations of the aggressiveness of thyroid cancer with microvessel density, expression of vascular endothelial growth factor and its receptors. J Korean Surg Soc. 2000;58:205-212
- Bosari S, Lee AK, Delellis RA, Wiley BD, Heatler GJ, Silveman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum PathoI 1992;23:755-761 https://doi.org/10.1016/0046-8177(92)90344-3
- Akslen LA, Livolsi VA: Increased angiogenesis in papillary carcinoma but lack of prognostic importance. Hum Pathol. 2000;31:439-442 https://doi.org/10.1053/1-ip.2000.6548
- Lennard CM, Patel A, Wilson J, et al: Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery. 2001;129:552-558 https://doi.org/10.1067/msy.2001.112592
- Fontanini G, Vignati S, Pacini F, Pollina L, Basolo F: Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. Mod Pathol. 1996;9:636-641
- Maeda K, Chung YS, Ogawa Y, et al: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-863 https://doi.org/10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A
- Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964-3968
- Eisma RJ, Spiro JD, Kreutzer DL: Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg. 1997;174:513-517 https://doi.org/10.1016/S0002-9610(97)00166-9
- Soh EY, Sobhi SA, Wong MG, et al: Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery. 1996;120:944-947. https://doi.org/10.1016/S0039-6060(96)80038-9
- Klein M, Picard E, Vignaud JM, et al: Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma. J Endocrinol. 1999;161:41-49 https://doi.org/10.1677/joe.0.1610041